The Technical Analyst
Select Language :
Kezar Life Sciences Inc [KZR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Kezar Life Sciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Kezar Life Sciences Inc is listed at the  Exchange

1.02% $0.903

America/New_York / 27 mar 2024 @ 16:00


Kezar Life Sciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 65.74 mill
EPS: -1.380
P/E: -0.650
Earnings Date: May 09, 2024
SharesOutstanding: 72.80 mill
Avg Daily Volume: 0.682 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.650 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.11x
Company: PE -0.650 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.265
(40.12%) $0.362
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.836 - 0.970

( +/- 7.42%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-15 Schiller Mark C. Sell 0 Common Stock
2024-01-15 Schiller Mark C. Sell 165 000 Employee Stock Option (right to buy)
2024-01-15 Schiller Mark C. Sell 250 000 Employee Stock Option (right to buy)
2024-01-07 Belsky Marc Buy 295 000 Employee Stock Option (right to buy)
2024-01-07 Mordwinkin Nicholas Michael Buy 275 000 Employee Stock Option (right to buy)
INSIDER POWER
-14.31
Last 100 transactions
Buy: 7 465 931 | Sell: 10 295 837

Forecast: 16:00 - $0.900

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.900
Forecast 2: 16:00 - $0.900
Forecast 3: 16:00 - $0.900
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.903 (1.02% )
Volume 0.516 mill
Avg. Vol. 0.682 mill
% of Avg. Vol 75.78 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Kezar Life Sciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Kezar Life Sciences Inc

RSI

Intraday RSI14 chart for Kezar Life Sciences Inc

Last 10 Buy & Sell Signals For KZR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Kezar Life Sciences Inc

KZR

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
SBDUSDMar 28 - 07:45$4.72
OETHUSDMar 28 - 07:453 570.56
NANOUSDMar 28 - 07:46$1.655
LDOUSDMar 28 - 07:452.94
^STOXXMar 28 - 07:31512.48
SCNSOLUSDMar 28 - 07:44219.77
P2PSUSDMar 28 - 07:43204.66
NQUSDMar 28 - 07:3418 478
^STOXX50EMar 28 - 07:28PTS5 093.01
YMUSDMar 28 - 07:3440 117

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.